Global Liquid Embolization System Market Strategic Research Report

Scope of the Report

The global Liquid Embolization System market size is predicted to grow from US$ 259 million in 2025 to US$ 421 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

Liquid embolization systems are injectable liquid embolic agents used in interventional radiology or neurosurgery. They are liquid at room temperature and, after being injected into the target blood vessel via a catheter, rapidly solidify or polymerize within the body, thereby permanently occluding abnormal blood vessels (such as those supplying arteriovenous malformations, aneurysms, or tumors). A typical product, the Onyx system, is primarily composed of ethylene-vinyl alcohol copolymer (EVOH), dimethyl sulfoxide (DMSO) solvent, and contrast agents (such as tantalum powder). It features non-adhesiveness, controllable flowability, and good contrast performance, and is widely used in minimally invasive treatment of cerebrovascular and peripheral vascular diseases. The upstream of the liquid embolization system industry chain mainly includes suppliers of polymer materials (such as EVOH), medical-grade solvents (DMSO), and contrast fillers (micron-sized tantalum powder); the midstream consists of R&D and manufacturing companies, with high technological barriers, currently dominated by multinational corporations such as Medtronic (owner of the Onyx system); and the downstream comprises tertiary hospital neurointerventional departments, interventional radiology departments, and stroke centers. In 2025, the global production of liquid embolization systems is estimated at approximately 221,000 units, with an average global market price of approximately US$1,200 per unit. The gross profit margin of major companies in the industry is between 65% and 80%. In 2025, the global production capacity of liquid embolization systems is estimated at approximately 294,000 units.

Global key Liquid Embolization System players cover Medtronic, Johnson & Johnson, Sirtex Medical, Instylla, NeuroSafe, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Liquid Embolization System market?

What factors are driving Liquid Embolization System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Liquid Embolization System market opportunities vary by end market size?

How does Liquid Embolization System break out by Type, by Application?

This report presents a comprehensive overview of the global Liquid Embolization System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• NBCA-based Liquid Embolic System
• Ethylene Vinyl Alcohol Copolymer (EVOH) System
• Polidocanol or Other Sclerosant Systems

Segment by Delivery System

• Microcatheter-Based Delivery
• Syringe Pump-Controlled Delivery
• Automated Injection System

Segment by Application

• Endovascular Embolization of AVMs
• Peripheral Vascular Malformation Treatment
• Cerebral Aneurysm Adjunct Treatment
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Liquid Embolization System market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Endovascular Embolization of AVMs, Peripheral Vascular Malformation Treatment, Cerebral Aneurysm Adjunct Treatment evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact